Target: Stroke, launched in 2010 by the American Heart Association, was a quality improvement initiative aimed at helping stroke centers reduce their door-to-needle treatment times.

At the 2019 International Stroke Conference, the AHA released phase III, which will give facilities the ability to be recognized for their efforts of faster door-to-needle times while also giving first-ever goals for Endovascular Treatment. Facilities who meet the new Phase III requirements will have the ability to be recognized starting in 2020.

Does your facility have a plan for meeting the new phase III goals?

If not, Pulsara should be your answer! Did you know the #1 reason for delayed treatment is communication breakdown? At Pulsara, we pride ourselves on our ability to place entire teams on the same communication channel - which research shows decreases treatment times and can help reduce medical errors secondary to miscommunication.

For more information on Target: Stroke Phase III click HERE

To find out how Pulsara can help YOU decrease treatment times at your facility and get you one step closer to meeting Target: Stroke Phase III Goals click HERE
Brittney Nelson, BSN, RN, SCRN

Written by Brittney Nelson, BSN, RN, SCRN

Brittney is a registered nurse and SCRN who served as the Stroke Coordinator at Trinity Mother Frances Hospital. Her passion for stroke patients and the acute stroke care process led her to her current position as Implementation Specialist at Pulsara.